Cingulate Inc. (NASDAQ:CINGW) Sees Large Increase in Short Interest

Cingulate Inc. (NASDAQ:CINGW) was the target of a significant growth in short interest during the month of March. As of March 13th, there was short interest totaling 9,399 shares, a growth of 281.0% from the February 26th total of 2,467 shares. Based on an average daily trading volume, of 48,976 shares, the short-interest ratio is presently 0.2 days. Based on an average daily trading volume, of 48,976 shares, the short-interest ratio is presently 0.2 days.

Cingulate Price Performance

NASDAQ:CINGW opened at $0.03 on Wednesday. Cingulate has a twelve month low of $0.02 and a twelve month high of $0.18. The company’s 50-day moving average price is $0.06 and its 200-day moving average price is $0.06.

About Cingulate

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.